CLAB.F Stock Overview
Operates as a psychedelic research and development company. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Core One Labs Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.11 |
52 Week High | CA$0.35 |
52 Week Low | CA$0.026 |
Beta | 0 |
11 Month Change | -9.48% |
3 Month Change | 6.50% |
1 Year Change | -32.47% |
33 Year Change | -83.98% |
5 Year Change | -98.75% |
Change since IPO | -99.26% |
Recent News & Updates
Recent updates
Shareholder Returns
CLAB.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 1.5% | 4.2% | 2.0% |
1Y | -32.5% | 13.7% | 32.4% |
Return vs Industry: CLAB.F underperformed the US Pharmaceuticals industry which returned 11.8% over the past year.
Return vs Market: CLAB.F underperformed the US Market which returned 32.6% over the past year.
Price Volatility
CLAB.F volatility | |
---|---|
CLAB.F Average Weekly Movement | 79.4% |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLAB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CLAB.F's weekly volatility has increased from 57% to 79% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | Joe Shacker | core1labs.com |
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation.
Core One Labs Inc. Fundamentals Summary
CLAB.F fundamental statistics | |
---|---|
Market cap | US$4.85m |
Earnings (TTM) | -US$15.98m |
Revenue (TTM) | US$458.54k |
0.0x
P/S Ratio0.0x
P/E RatioIs CLAB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLAB.F income statement (TTM) | |
---|---|
Revenue | CA$458.54k |
Cost of Revenue | CA$0 |
Gross Profit | CA$458.54k |
Other Expenses | CA$16.44m |
Earnings | -CA$15.98m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CLAB.F perform over the long term?
See historical performance and comparison